Assessing right ventricular function in patients with hypertrophic cardiomyopathy with cardiac MRI: correlation with

Shuai Zhang1, Zhi-Gang Yang1, Jia-Yu Sun1

  • 1Department of Radiology, National Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.

Plos One
|September 3, 2014
PubMed

Insights

3.0-T MRI effectively assesses right ventricular (RV) function in hypertrophic cardiomyopathy (HCM) patients. RV dysfunction on MRI predicts severe symptomatic HCM, correlating with advanced New York Heart Association (NYHA) classification.

Area of Science:

  • Cardiology
  • Radiology
  • Medical Imaging

Background:

  • Hypertrophic cardiomyopathy (HCM) is a genetic heart disease characterized by left ventricular hypertrophy.
  • Right ventricular (RV) involvement is common in HCM and can impact prognosis.
  • Accurate assessment of RV function is crucial for managing HCM patients.

Purpose of the Study:

  • To evaluate the utility of 3.0-Tesla (3.0-T) magnetic resonance imaging (MRI) in assessing RV function in HCM patients.
  • To determine the correlation between RV function parameters measured by MRI and the New York Heart Association (NYHA) functional classification.

Main Methods:

  • Forty-six HCM patients and 23 controls underwent 3.0-T MRI to measure left and right ventricular function and dimensions.
  • Ventricular volumes (end-diastolic [EDV], end-systolic [ESV]), stroke volume (SV), and ejection fraction (EF) were analyzed.
  • Statistical analyses, including independent t tests, ANOVA, and Receiver Operating Characteristic (ROC) analyses, were performed.

Main Results:

  • Significant differences in ventricular volumetric values and masses were observed between HCM patients and controls (p<0.05).
  • RV end-diastolic diameter (RVEDD) correlated with left ventricular end-diastolic diameter (LVEDD) (r=0.53; p<0.001).
  • Patients with NYHA Class IV demonstrated significantly impaired RV and LV systolic and diastolic function compared to Classes I-III (P<0.0167).
  • ROC analyses identified EDV, ESV, and EDD of both ventricles as predictors of severe heart failure (NYHA Class IV) with high sensitivity and specificity.

Conclusions:

  • RV involvement in HCM is comparable to LV global function impairments.
  • 3.0-T MRI is a valuable tool for detecting RV dysfunction in HCM.
  • MRI-detected RV dysfunction and decreased dimensions can predict severe symptomatic HCM.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
801
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
1.1K
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
932
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
549
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
836
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
809